T2/FLAIR hyperintensities: the bright spots on a brain MRI

What “hyperintense” actually describes

MRI does not have one picture. It has a set of them, each taken with different settings, and the same tissue looks different in each. “Hyperintense” means brighter than its surroundings on the sequence being described, and “hypointense” means darker. Neither word says anything about health on its own — it is the radiologist telling another clinician what the pixel did.

T2 is the sequence on which water is bright. FLAIR is a T2 image with one modification: the signal from plain, free-flowing fluid is suppressed, so the fluid-filled ventricles in the middle of the brain go black. That matters, because it means anything still bright on FLAIR is holding water inside tissue rather than being fluid itself. It is the sequence built to make exactly this finding visible, which is why almost every report that mentions these spots names it.

This is also why the same brain can produce an alarming-looking MRI and a completely normal CT. CT is far less sensitive to this kind of change. A head CT reported as normal does not mean an MRI would have been.

Why so many reports mention them

Small T2/FLAIR hyperintensities in the white matter are among the most frequently reported findings in brain imaging, and their frequency rises steadily with age. They are found in people scanned for headache, for dizziness, after a minor head injury, and in people scanned for something else entirely. In middle age a handful of small spots is a common report; by the seventies and eighties, some degree of change is more usual than not.

That frequency is the single most useful thing to know about them, because it reframes what the report is doing. The radiologist is required to describe what is visible. Describing an extremely common age-related appearance is not the same as flagging a problem, and the report has no way of sounding casual about it.

• Age is the strongest association. So are long-standing high blood pressure, diabetes and smoking, which is why the report may recommend that vascular risk factors be reviewed.
• Migraine is associated with small white matter spots, in people with otherwise entirely normal brains.
• Old injury, previous infection and inflammation leave marks that look the same years later.
• Some spots have no identifiable cause at all, which is what “nonspecific” in the report is admitting.

What “small vessel ischemic disease” means, and why it sounds worse than it is

When the spots sit deep in the white matter and are scattered rather than clustered, most reports name the pattern: chronic small vessel ischemic change, microvascular ischemic disease, or chronic microvascular changes. All three describe the same thing — the cumulative effect on the brain’s smallest arteries of years of ordinary wear, blood pressure and ageing.

Three words in that phrase do most of the frightening. “Ischemic” means reduced blood supply, and to most people means a stroke. “Disease” means a diagnosis. “Small vessel” gets skipped. Read as radiologists use it, the phrase describes a slow, chronic, extremely common process in vessels a fraction of a millimetre across — not an event, not something happening now, and not the same category of thing as the sudden blockage of a large artery that causes a stroke.

Why the radiologist describes where they are

The number of spots matters less than where they sit and what shape they are, because that is the only handle the images give on the cause. This is why a report will spend a sentence on location that reads like padding and is not.

• Deep in the white matter, scattered, small and round is the common vascular pattern.
• Right against the ventricles, oval, and oriented perpendicular to them is a pattern that raises other possibilities, which is when a report starts mentioning them by name.
• Involving the corpus callosum, the brainstem or the cerebellum changes the reading again.
• A single spot in a specific place, in a young person, is read completely differently from a dozen scattered spots in a person of seventy.

None of that is something to work out from your own report. It is the reason the report exists in the form it does, and the reason the sentence after the finding so often asks for the images to be read next to your age, your history and your symptoms.

The Fazekas scale: what the number counts

Where a report gives a grade, it is usually the Fazekas scale — a four-point description of how much white matter change is present, used because “a few spots” means different things to different readers. It grades the appearance, in two regions, and nothing else.

1. 1.Fazekas 0

   No white matter change, or a single tiny focus. The scale exists to have a floor as well as a ceiling.

2. 2.Fazekas 1

   Separate, punctate spots — individual dots that do not touch each other. This is the grade most commonly reported in people with no symptoms.

3. 3.Fazekas 2

   Spots that have started to run together into patches, described as beginning confluence.

4. 4.Fazekas 3

   Large confluent areas: the changes have merged into continuous regions rather than separate spots.

A grade is a measure of appearance, not of function. People at the same grade differ enormously, and the number is meaningful mainly for comparison against a later scan and alongside a clinical assessment. It is not a score of how ill you are, and it is not a prediction.

What is worth asking at the appointment

The useful questions are about what the finding is being connected to, not about the finding itself.

• Does this pattern fit my age, or is it more than expected? That comparison is the whole interpretation and it is not in the report.
• Is anything here worth acting on — blood pressure, cholesterol, blood sugar, smoking? Where the changes are vascular, these are the levers, and they are ordinary ones.
• Does this explain my symptoms, or is it an incidental finding? These are often reported in people scanned for something the spots have nothing to do with.
• Is a follow-up scan planned, and when? Change over time says far more than any single study.